| Literature DB >> 26872963 |
Dominik Linz1, Henrik Fox2, Thomas Bitter2, Jens Spießhöfer3, Christoph Schöbel4, Erik Skobel5, Anke Türoff6, Michael Böhm7, Martin R Cowie8, Michael Arzt9, Olaf Oldenburg2.
Abstract
Sleep disordered breathing (SDB) (obstructive sleep apnea, central sleep apnea/Cheyne-Stokes respiration or the combination of both) is highly prevalent in patients with a wide variety of cardiovascular diseases including hypertension, arrhythmia, coronary artery disease, myocardial infarction and stroke (reviewed previously in the September issue of this journal). Its close association with outcomes in chronic heart failure with reduced ejection fraction (HF-REF) suggests that it may be a potential treatment target. Herein, we provide an update on SDB and its treatment in HF-REF.Entities:
Keywords: Adaptive servoventilation; Arrhythmias; Heart failure; SERVE-HF; Sleep apnea
Mesh:
Year: 2016 PMID: 26872963 DOI: 10.1007/s00392-016-0970-4
Source DB: PubMed Journal: Clin Res Cardiol ISSN: 1861-0684 Impact factor: 5.460